|INTRODUCTION||ABOUT THE PROJECT||CHRONICALLY SICK CHILD||INDIVIDUALIZATION OF THERAPY||PROJECT OUTPUTS|
|DURING THE PROJECT||ABOUT THE LABORATORY||PUBLICITY||PHOTOGALLERY||REFERENCES|
The basic need of the project is improving the quality of life in child patients suffering from asthma and non-specific inflammation diseases. Also necessary is identification of factors that may improve the diagnostics and affect the drug response.
The task which the project adopts in order to fulfil the basic need is formulated as follows: improving our knowledge of mechanisms affecting the therapy response with the subsequent outlook for optimisation of the therapy on the basis of the genomic and expressional analysis.
The results achieved by the project will include: establishing the pharmacogenomic profile of the patient suffering from asthma or inflammatory bowel diseases, as well as assessment of the therapy response. Assessment of the expressional profile for specifically defined populations of lymphocytes which participate in the inflammatory response.
Supported by grant from Island, Lichtenstein a Norway in the frame of Financial mechanism EHP.